G (Genpact) Other Long-Term Liabilities: $190 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

G Genpact Ltd G
80 GF Score
Price $34.79
GF Value $46.78
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Genpact Other Long-Term Liabilities?

Genpact G +3.23% 80 Other Long-Term Liabilities is $190 Mil as of Jun. 2026. GuruFocus rates G with a GF Score™ of 80/100 and a GF Value™ of $46.78 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Genpact's other long-term liabilities for the quarter that ended in Jun. 2026 was $190 Mil.

Genpact's quarterly other long-term liabilities increased from Dec. 2025 ($152 Mil) to Mar. 2026 ($189 Mil) and increased from Mar. 2026 ($189 Mil) to Jun. 2026 ($190 Mil).

Genpact's annual other long-term liabilities increased from Dec. 2023 ($53 Mil) to Dec. 2024 ($88 Mil) and increased from Dec. 2024 ($88 Mil) to Dec. 2025 ($152 Mil).


Genpact Other Long-Term Liabilities Related Terms


Genpact Other Long-Term Liabilities Historical Data

* Premium members only.

The historical data trend for Genpact's Other Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genpact Other Long-Term Liabilities Chart

Genpact Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Long-Term Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.89 79.36 53.18 87.56 152.03

Genpact Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.93 144.93 152.03 188.99 190.47
G
80GF Score
Genpact Ltd G
Other Long-Term Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Genpact Other Long-Term Liabilities Calculation

Other Long-Term Liabilities are the other liabilities on the balance sheet that do not need to be repaid within the next 12 months, but still need to be repaid over time. For instance, on Wal-Mart's balance sheet, there are items called Long Term obligations under capital leases, deferred income taxes, and redeemable non-controlling interest. These are all Other Long-Term Liabilities.

What does a Other Long-Term Liabilities of $190 Mil mean?
Genpact (G) has a Other Long-Term Liabilities of $190 Mil as of Jun. 2026. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Genpact and its competitors.
Is Genpact's Other Long-Term Liabilities too high?
Genpact's current Other Long-Term Liabilities is $190 Mil. Overall, Genpact has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Genpact's Other Long-Term Liabilities compare to SAIC and EPAM?
Genpact's Other Long-Term Liabilities of $190 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long-Term Liabilities for a Software company?
A good Other Long-Term Liabilities depends on the Software industry context. However, Other Long-Term Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long-Term Liabilities mean?
A high Other Long-Term Liabilities can signal that a stock is expensive relative to its fundamentals. Other long-term liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Genpact and its competitors. Genpact's current Other Long-Term Liabilities is $190 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genpact stock overvalued right now?
Based on GuruFocus' analysis, Genpact (G) is currently considered Modestly Undervalued. The stock's GF Value™ is $46.78, compared to a current price of $34.79 — trading 25.6% below its estimated fair value. The current Other Long-Term Liabilities is $190 Mil. Genpact's overall GF Score™ is 80/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long-Term Liabilities calculated?
Other Long-Term Liabilities is calculated from a company's financial statements. For Genpact (G), the current Other Long-Term Liabilities is $190 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Genpact (G) Overvalued in 2026?

Based on GuruFocus' analysis, Genpact stock appears to be undervalued. The current stock price of $34.79 is trading 25.6% below its estimated GF Value™ of $46.78. GuruFocus considers Genpact to be Modestly Undervalued.

Key valuation signals for G:

  • Other Long-Term Liabilities: $190 Mil
  • GF Value™: $46.78 vs. price of $34.79 (25.6% below fair value)
  • GF Score™: 80/100 with 1 warning sign

No single metric tells the full story. See the G stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Genpact Business Description

Other Exchanges 35G:Germany
Address 22 Victoria Street, Canon\'s Court, Hamilton, BMU, HM 12
Genpact Ltd is an agentic, technology-solutions company offering digital transformation, data-driven operations, and technology-enabled services across multiple industries. Its core business services include decision support services; technology services like application lifecycle management, platform customization, and support, etc; and digital operations optimizing business processes. Genpact also offers data engineering, data management, and domain-based AI and generative AI solutions; develops new technology solutions for clients; and offers agentic solutions and technology consulting services. Its reportable segments are: High Tech and Manufacturing, which generate maximum revenue, Financial Services, and Consumer and Healthcare. Geographically, it derives maximum revenue from India.
80GF Score

Get the complete analysis for G

Other Long-Term Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$34.79
Price
$46.78
GF Value